BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 15087453)

  • 1. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.
    Milutinovic S; Brown SE; Zhuang Q; Szyf M
    J Biol Chem; 2004 Jul; 279(27):27915-27. PubMed ID: 15087453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
    Estève PO; Chin HG; Pradhan S
    J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control elements of Dnmt1 gene are regulated in cell-cycle dependent manner.
    Kishikawa S; Murata T; Ugai H; Yamazaki T; Yokoyama KK
    Nucleic Acids Res Suppl; 2003; (3):307-8. PubMed ID: 14510503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
    Xiao H; Hasegawa T; Isobe K
    J Cell Biochem; 1999 Jun; 73(3):291-302. PubMed ID: 10321829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins.
    Kishikawa S; Murata T; Kimura H; Shiota K; Yokoyama KK
    Eur J Biochem; 2002 Jun; 269(12):2961-70. PubMed ID: 12071960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of histone acetylation in the Dnmt1 gene expression.
    Kishikawa S; Ugai H; Murata T; Yokoyama KK
    Nucleic Acids Res Suppl; 2002; (2):209-10. PubMed ID: 12903179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.
    Wu LP; Wang X; Li L; Zhao Y; Lu S; Yu Y; Zhou W; Liu X; Yang J; Zheng Z; Zhang H; Feng J; Yang Y; Wang H; Zhu WG
    Mol Cell Biol; 2008 May; 28(10):3219-35. PubMed ID: 18332107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
    Choi HS; Lee JH; Park JG; Lee YI
    Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
    Stimson KM; Vertino PM
    J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
    Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE
    Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.
    Kramps C; Strieder V; Sapetschnig A; Suske G; Lutz W
    J Biol Chem; 2004 Feb; 279(7):5110-7. PubMed ID: 14645238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3.
    Aoyama T; Okamoto T; Nagayama S; Nishijo K; Ishibe T; Yasura K; Nakayama T; Nakamura T; Toguchida J
    J Biol Chem; 2004 Jul; 279(27):28789-97. PubMed ID: 15107420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
    Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
    Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor.
    Xiao H; Hasegawa T; Isobe K
    J Biol Chem; 2000 Jan; 275(2):1371-6. PubMed ID: 10625687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of murine H-rev107 gene expression by growth arrest and histone acetylation: involvement of an Sp1/Sp3-binding GC-box.
    Roder K; Kim KH; Sul HS
    Biochem Biophys Res Commun; 2002 May; 294(1):63-70. PubMed ID: 12054741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.